State Street’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

State Street’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,590,606	Closed	-$53.8M	–	4756
2021 Q2	$53.8M	Sell	1,590,606 -603,808	-28%	-$15.4M	﹤0.01%	1788
2021 Q1	$51.3M	Buy	2,194,414 +537,107	+32%	+$16.3M	﹤0.01%	1733
2020 Q4	$47.7M	Sell	1,657,307 -509,506	-24%	-$12.8M	﹤0.01%	1664
2020 Q3	$43.9M	Buy	2,166,813 +787,142	+57%	+$19.2M	﹤0.01%	1558
2020 Q2	$41.5M	Buy	1,379,671 +1,028,027	+292%	+$37M	﹤0.01%	1569
2020 Q1	$11.1M	Buy	351,644 +77,400	+28%	+$2.69M	﹤0.01%	2222
2019 Q4	$12.9M	Buy	274,244 +21,214	+8%	+$612K	﹤0.01%	2402
2019 Q3	$1.64M	Sell	253,030 -409	-0.2%	-$3.42K	﹤0.01%	3282
2019 Q2	$3.11M	Buy	253,439 +75,389	+42%	+$839K	﹤0.01%	3060
2019 Q1	$2.41M	Buy	178,050 +161,156	+954%	+$1.44M	﹤0.01%	3079
2018 Q4	$68K	Buy	+16,894	New	+$102K	﹤0.01%	3660

State Street's CNST Position: Q3 2021 in Review

State Street sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,590,606 shares — an estimated $53.8M sold.

State Street first reported a position in CNST in Q4 2018 and held it in 11 quarters. The position peaked at $53.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

State Street reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
State Street sold 1,590,606 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $53.8M.
State Street first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2018 and held it in 11 quarters.
State Street's Constellation Pharmaceuticals, Inc. position peaked at $53.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.